GE HealthCare Technologies (GEHC) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.34
- Estimate
- $1.20
- Surprise
- +11.3%
- Revenue (period 2026-09-30)
- $5.51B
- Score at report (before → after)
- 5.9 → 5.9/10
Revenue source: xbrl.
How the report landed
GE HealthCare Technologies (GEHC) beat the $1.20 estimate with adjusted EPS of $1.34 — a large 11.3% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.9/10) to Hold at 5.9/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates GEHC Hold at 5.9/10.
3 of the last 4 quarters beat the estimate; this quarter's +11.3% surprise compares with a +4.4% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Analyst target reached - limited upside remaining
- V7 low-quality RISK_OFF penalty: -0.5 (Q=5.4)
- Overbought (RSI 82)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $75.82
- Stop
- $71.44
At 16.0× trailing and 13.9× forward earnings, consensus estimates imply little change in earnings power.
Risk check: RSI 82 — a level conventionally read as overbought; gains at these levels often lean on momentum; trading volume is running 2.5× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-10-29 — shown for context, not personalized investment advice.
GEHC at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $34.49B
- P/E (fwd)
- 13.9
- P/E (ttm)
- 16.0
- 52-week range
- $58.75–$89.77
- Off 52-week high
- 15.5%
- RSI (14)
- 82
- Volume vs avg
- 2.53×
- Score today
- 5.9/10